Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Sep 01, 2022 2:26pm
229 Views
Post# 34936109

RE:RE:Our Team

RE:RE:Our Team
Yajne wrote: The more I think about these departures, it might simply come down to cost-cutting to stretch our their cash. Q2 burn rate was just over $400K/mo, with cash sitting at less than $1.5million on June 30. 

Eoganacht wrote: I just checked out the "Our Team" page on the Theralase website. Not only has Dr. Vera disappeared but also the Investor Relations Coordinator. So much for resuming quarterly newsletters...




 

I also think her departure could have simply been related to cost-saving measures...nothing personal or professional.  Just begs the question why she wasn't hired as a consultant in the first place with such a tight budget.   JMO.

<< Previous
Bullboard Posts
Next >>